Delivery Order SPE2DB20D3103-SPE2DB22FP9W1
Award Date
9/22/22
Potential Completion Date
9/23/22
Potential Value
$6.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,437.17 firm fixed-price delivery order is for 4563844946 LOTREL 10-20 MG CAPSULE 100S, with a period of performance ending on March 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,247 Firm Fixed Price Delivery Order contract is for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of May 10, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,874.88 firm fixed-price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of April 19, 2024. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the federal government - a $999,999,999 IDC with the DLA...
This federal contract award with ID SPE2DB20D3103|SPE2DB24FN1Y8 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,564,085,731 units of the pharmaceutical product LOTREL 10-20 MG CAPSULE 100S. The firm-fixed-price delivery order has a ceiling value of $23,021.48 and a completion date of March 27, 2024. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug...
This federal contract award, with ID SPE2DB22D7058|SPE2DB25FSUW8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order valued at $3,186.18 and has a firm fixed price pricing type. It is for the supply of 4567397634 ! LOTREL 10-20 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of February 28, 2025 and was awarded on February 27, 2025. Amerisourcebergen Drug Corp is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,418.86 firm fixed-price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, with ID SPE2DB20D3101|SPE2DB23FRHY2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,913.57 firm fixed-price delivery order is for the supply of LOTREL 5-20 MG CAPSULE 100S, a cardiovascular medication. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of $81,406.88 worth of LOTREL 10-20 MG CAPSULE 100S. This delivery order falls under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This federal contract award, with ID SPE2DB20D2104|SPE2DB24FS72V, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The $2,711.07 firm fixed price delivery order is for the supply of 4563755805 LOTREL 10-20 MG CAPSULE 100S, a pharmaceutical product. The contract has a period of performance through February 26, 2024. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The firm-fixed-price delivery order, valued at $2,349.59, has a completion date of June 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...